Skip to content
Screener

BillionToOne, Inc. BLLN EV / EBITDA

EV / EBITDA at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
13.3×-1.4×
Illumina logo
IlluminaILMN
17.7×—
Revvity logo
RevvityRVTY
16.7×-2.2×
Progyny logo
ProgynyPGNY
12.6×-11.2×
GeneDx Holdings logo
GeneDx HoldingsWGS
310.1×—
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
9.1×—

Other financials

Income statement

See full
Revenue$109.4M+64.4%
Gross profit$77.1M+77.4%
Operating income$5.5M+438%
Net income$8.1M+3,374%
EPS (diluted)$0.15+850%

Balance sheet

See full
Cash & equivalents$548.6M+190%
Total debt$143.9M—
Total equity$536.8M+315%
Total assets$729.7M—

Cash flow

See full
Operating cash flow$9.1M+673%
CapEx$4.0M+40.9%
Free cash flow$5.1M+401%

Valuation

See full
Market cap$6.9B+56.7%
Enterprise value$6.49B—
P/E182.9×—
P/S17.4×—

Profitability

See full
Gross margin71.3%+10.3pp
Operating margin10.9%+7.0pp
Net margin9.5%+5.9pp
FCF margin8.3%—

Returns & leverage

See full
Return on equity26.3%—
Debt / equity0.3×—
Current ratio11.7×—

Where this comes from

Calculated from BillionToOne, Inc.’s reported figures.

enterprise value/ebitda=101.8×

Based on the most recent quarter.

The source filing: BillionToOne, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:42 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0002070849-26-000050

FAQ

What is BillionToOne, Inc.'s EV / EBITDA?
BillionToOne, Inc. (BLLN) reported EV / EBITDA of 101.8× in Q2 2026.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about BillionToOne, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude